Task: Answer the multiple-choice question.
Question: Which drug exhibits a 11.145\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CC(=O)N/C(=C\c1cccs1)C(=O)O
b.) CC1CN(S(=O)(=O)c2ccc(F)cc2)C(C)N1C(=O)N1CCOCC1
c.) C=CCn1c(C(C)NC(=O)CC)nc2ccccc21
Answer: c. C=CCn1c(C(C)NC(=O)CC)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCn1c(C(C)NC(=O)CC)nc2ccccc21
C=CCn1c(C(C)NC(=O)CC)nc2ccccc21
N-[1-(1-prop-2-enylbenzimidazol-2-yl)ethyl]propanamide